News
Moderna to Build State-of-the-Art mRNA Facility in Africa to Manufacture up to 500 Million Doses Per Year
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced it will build a state-of-the-art mRNA facility in Africa with the goal of producing up to 500 million doses of vaccines each year at the 50...
Drug Research
Metrics Contract Services Enters Partnership to Develop Oncology Drug
Metrics Contract Services, the US-based contract pharmaceutical development and manufacturing division of Mayne Pharma, announced the signing of a development and manufacturing agreement with ESSA Pharmaceuticals. Under the terms of the agreement, Metrics will provide formulation development, analytical services...
Drug Research
Pistoia Alliance President Warns Pharmaceutical Industry Not to Undo the Advances it has Made During the Pandemic
Tackling global public health crises will require industry to continue overcoming trust issues and accelerate the safe sharing of anonymized patient data
Dr Steve Arlington, President of The Pistoia Alliance, a global not-for-profit advocating for greater collaboration in biopharma, is...
News
Andaman7 Achieves Global eHealth Interoperability
Belgian-American e-health company Andaman7 is celebrating a ‘world first’ after patients collected their health data via their smart phone from both US and EU-based hospitals. The moment marked a major milestone in global health interoperability and patient empowerment.
Andaman7 was...
News
Catalent Opens New Full-Service Clinical Supply Facility in Shiga, Japan
Catalent, a global leader in clinical supply services, announced the opening of its new clinical supply facility, strategically located in the Shiga prefecture of Japan, in response to increased demand for end-to-end services, including primary packaging and white glove...
Drug Research
Merck Licenses Foundational CRISPR Technology to Cellecta, Paving Path for Development of Next-Generation Treatments
Merck, a leading science and technology company, announced that its Life Science business sector has signed an agreement licensing its patented CRISPR-Cas9 technology to Cellecta, Inc., a functional genomics products and services provider based in Mountain View, California, USA....
News
Takeda to Commercialize Next-Generation Hunter Syndrome Therapy Through Collaboration with JCR Pharmaceuticals
Takeda Pharmaceutical Company Limited and JCR Pharmaceuticals Co., Ltd. announced a geographically-focused exclusive collaboration and license agreement to commercialize JR-141, an investigational, next-generation recombinant fusion protein of an antibody against the human transferrin receptor and iduronate-2-sulfatase (IDS) enzyme for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read